Skip to main content
. 2018 Dec 14;24:9073–9080. doi: 10.12659/MSM.910480

Figure 5.

Figure 5

Alteration of serum ALP activity can predict the different prognoses of GC patients. (A) Among the 404 patients who had a pre-treatment serum ALP activity ≤150 U/L, 47 experienced an elevation of serum ALP after treatment and their DFS were significantly inferior than other 357 patients whose serum ALP activity were still ≤150 U/L, P=0.018. (B) Among the 87 patients who had a pre-treatment serum ALP activity >150 U/L, 56 experienced a decline of serum ALP after treatment and their DFS were superior than other 31 patients whose serum ALP activity were still >150 U/L, P=0.004.